Brexpiprazole

Brand Name: Rexulti

Type: Atypical Antipsychotic

Used For: Schizophrenia and related depression.

Approval Year: 2015

Description: It is a dopamine D₂ receptor partial agonist and has been described as a "serotonin–dopamine activity modulator".